2-(2,3-Difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACNICW372
CAS No. :
1953170-33-6
Molecular Formula :
C13H17BF2O2
Molecular Weight :
254.09

IUPAC Name:2-(2,3-difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(2,3-Difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2,3-Difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(2,3-difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD18251194
Molecular FormulaC13H17BF2O2
Molecular Weight254.09
SMILESCC1(C)C(C)(C)OB(CC2=CC=CC(F)=C2F)O1
InChI KeyXWMWEOZUDRJYMO-UHFFFAOYSA-N
Synonym1,3,2-Dioxaborolane, 2-[(2,3-difluorophenyl)methyl]-4,4,5,5-tetramethyl-;2-(2,3-difluorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS No.1953170-33-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNICW372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACMLFB867 route compound structure diagram
    ACMLFB867113211-94-2 In Stock
  4. Then
  5. ACNICW372 route product structure diagram
    ACNICW3721953170-33-6
Inquiry

2. ACNICW372 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  2. Plus
  3. ACMLFB867 route compound structure diagram
    ACMLFB867113211-94-2 In Stock
  4. Then
  5. ACNICW372 route product structure diagram
    ACNICW3721953170-33-6
Inquiry

Comments (0)